Nasdaq · CIK 0000883984
ICUI ICU MEDICAL INC/DE
Insider trading from SEC Form 4. Last filing 39 d ago. Close $160.32 on Oct 9, 2026, +40% from the 52-week low and -14% from the high.
Last 90 days
Net insider value
-$1.9M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1.9M by 2 insiders
Insiders on file
12
with a Form 4 at this company
Price and insider trades, last year
ICUIOct 9, 2026 · close 160.32
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ICU MEDICAL INC/DE, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Virginia Ruth Sanzone VP, General Counsel sell | $819k 4,856 shares | -25% | - | |
| 40Moderate | Brian Michael Bonnell Chief Financial Officer sell | $1.1M 6,381 shares | -10% | - | |
| 40Moderate | Virginia Ruth Sanzone VP, General Counsel sell | $94k 700 shares | -10% | +5% from low-27% from high | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.3M 9,930 shares | -95% | +1% from low-29% from high | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.3M 9,918 shares | -107% | +1% from low-29% from high | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.3M 9,788 shares | -123% | +4% from low-27% from high | |
| 44Moderate | Elisha W Finney director sell | $83k 600 shares | -16% | +6% from low-25% from high | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.5M 11,110 shares | -140% | +9% from low-23% from high | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.5M 11,111 shares | -140% | +5% from low-26% from high | |
| 63Notable | Ben Sousa Chief Information Officer sell | $275k 2,000 shares | -81% | +8% from low-24% from high | |
| 34Weak | David C. Greenberg director sell | $279k 1,942 shares | -22% | +10% from low-22% from high | |
| 2Weak | Vivek Jain Chairman and CEO sell | $213k 1,373 shares | -1% | - | |
| 50Moderate | Daniel Woolson VP, GM-Infusion Capital sell | $350k 2,241 shares | -17% | - | |
| 35Weak | Vivek Jain Chairman and CEO sell | $2.0M 12,000 shares | -10% | - | |
| 31Weak | David C. Greenberg director sell | $154k 972 shares | -16% | - | |
| 53Moderate | Christian B. Voigtlander Chief Operating Officer sell | $226k 1,430 shares | -100% | - | |
| 65Notable | Christian B. Voigtlander Chief Operating Officer sell | $1.6M 9,681 shares | -493% | - | |
| 20Weak | Vivek Jain Chairman and CEO sell | $2.1M 12,000 shares | -10% | - |
Congressional trades
1 trade in ICUI disclosed by members of Congress under the STOCK Act. All congressional trades.
- Gilbert Ray Cisneros, Jr.House · D-CA · last Jun 6, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | ICUI ICU Medical, Inc. - Common Stock | $1,001 to $15k | May 6, 2025 / Jun 6, 2025 31 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Virginia Ruth Sanzone VP, General Counsel | SOpen-market sale Common Stock10b5-1 | -2,202 | $167.67 | $369k | 17,258 | 39 d ago |
| Sep 3, 2026 | Virginia Ruth Sanzone VP, General Counsel | SOpen-market sale Common Stock10b5-1 | -1,238 | $168.44 | $209k | 16,020 | 39 d ago |
| Sep 3, 2026 | Virginia Ruth Sanzone VP, General Counsel | SOpen-market sale Common Stock10b5-1 | -724 | $169.53 | $123k | 15,296 | 39 d ago |
| Sep 3, 2026 | Virginia Ruth Sanzone VP, General Counsel | SOpen-market sale Common Stock10b5-1 | -692 | $171.52 | $119k | 14,604 | 39 d ago |
| Sep 1, 2026 | Brian Michael Bonnell Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -6,381 | $175.00 | $1.1M | 56,062 | 41 d ago |
| May 30, 2025 | Virginia Ruth Sanzone VP, General Counsel | SOpen-market sale Common Stock | -700 | $133.62 | $94k | 6,386 | May 30, 2025 |
| May 27, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 10,458 | May 28, 2025 |
| May 27, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,945 | $131.00 | $648k | 5,513 | May 28, 2025 |
| May 28, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,560 | $96.83 | $538k | 11,073 | May 28, 2025 |
| May 28, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,985 | $128.50 | $641k | 6,088 | May 28, 2025 |
| May 27, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 5,560 | May 28, 2025 |
| May 28, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,560 | $0.00 | $0 | 0 | May 28, 2025 |
| May 22, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 9,266 | May 23, 2025 |
| May 22, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,959 | $130.03 | $645k | 4,307 | May 23, 2025 |
| May 23, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 9,862 | May 23, 2025 |
| May 23, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,959 | $130.00 | $645k | 4,903 | May 23, 2025 |
| May 22, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 16,670 | May 23, 2025 |
| May 23, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 11,115 | May 23, 2025 |
| May 20, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 7,944 | May 21, 2025 |
| May 20, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,871 | $137.11 | $668k | 3,073 | May 21, 2025 |
| May 21, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 8,628 | May 21, 2025 |
| May 21, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -4,917 | $133.00 | $654k | 3,711 | May 21, 2025 |
| May 20, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 27,780 | May 21, 2025 |
| May 21, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 22,225 | May 21, 2025 |
| May 19, 2025 | Elisha W Finney director | SOpen-market sale Common Stock | -600 | $138.92 | $83k | 3,252 | May 20, 2025 |
| May 16, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 7,944 | May 19, 2025 |
| May 16, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -5,555 | $140.00 | $778k | 2,389 | May 19, 2025 |
| May 19, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 7,944 | May 19, 2025 |
| May 19, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -5,555 | $138.00 | $767k | 2,389 | May 19, 2025 |
| May 16, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 38,890 | May 19, 2025 |
| May 19, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 33,335 | May 19, 2025 |
| May 15, 2025 | Ben Sousa Chief Information Officer | SOpen-market sale Common Stock | -2,000 | $137.36 | $275k | 479 | May 15, 2025 |
| May 14, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,556 | $96.83 | $538k | 7,945 | May 15, 2025 |
| May 14, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -5,556 | $138.65 | $770k | 2,389 | May 15, 2025 |
| May 15, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +5,555 | $96.83 | $538k | 7,944 | May 15, 2025 |
| May 15, 2025 | Christian B. Voigtlander Chief Operating Officer | SOpen-market sale Common Stock | -5,555 | $135.55 | $753k | 2,389 | May 15, 2025 |
| May 14, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,556 | $0.00 | $0 | 50,000 | May 15, 2025 |
| May 15, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -5,555 | $0.00 | $0 | 44,445 | May 15, 2025 |
| May 13, 2025 | Elisha W Finney director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 3,852 | May 14, 2025 |
| May 13, 2025 | Elisha W Finney director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 14, 2025 |
| May 13, 2025 | Elisha W Finney director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 14, 2025 |
| May 13, 2025 | Donald Abbey director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 4,750 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 6,760 | May 13, 2025 |
| May 13, 2025 | Laurie Hernandez director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 3,608 | May 13, 2025 |
| May 13, 2025 | David F Hoffmeister director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 4,750 | May 13, 2025 |
| May 13, 2025 | Kolleen T Kennedy director | MOption exercise Common Stock | +1,723 | $0.00 | $0 | 3,285 | May 13, 2025 |
| May 13, 2025 | Donald Abbey director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | MOption exercise Common Stock | +1,942 | $94.68 | $184k | 8,702 | May 13, 2025 |
| May 13, 2025 | Laurie Hernandez director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
| May 13, 2025 | David F Hoffmeister director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | Kolleen T Kennedy director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | Donald Abbey director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | SOpen-market sale Common Stock | -1,942 | $143.66 | $279k | 6,760 | May 13, 2025 |
| May 13, 2025 | Laurie Hernandez director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | David F Hoffmeister director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
| May 13, 2025 | Kolleen T Kennedy director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | MOption exercise Common Stockderivative | -1,723 | $0.00 | $0 | 0 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | AGrant or award Common Stockderivative | +1,254 | $0.00 | $0 | 1,254 | May 13, 2025 |
| May 13, 2025 | David C. Greenberg director | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -1,942 | $0.00 | $0 | 0 | May 13, 2025 |
| Mar 15, 2025 | Virginia Ruth Sanzone VP, General Counsel | MOption exercise Common Stock | +1,624 | $0.00 | $0 | 7,984 | Mar 17, 2025 |
| Mar 15, 2025 | Daniel Woolson VP, GM-Infusion Capital | MOption exercise Common Stock | +2,923 | $0.00 | $0 | 15,488 | Mar 17, 2025 |
| Mar 15, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +3,248 | $0.00 | $0 | 4,181 | Mar 17, 2025 |
| Mar 15, 2025 | Ben Sousa Chief Information Officer | MOption exercise Common Stock | +1,299 | $0.00 | $0 | 3,195 | Mar 17, 2025 |
| Mar 15, 2025 | Brian Michael Bonnell Chief Financial Officer | MOption exercise Common Stock | +3,248 | $0.00 | $0 | 30,348 | Mar 17, 2025 |
| Mar 15, 2025 | Vivek Jain Chairman and CEO | MOption exercise Common Stock | +4,872 | $0.00 | $0 | 110,908 | Mar 17, 2025 |
| Mar 15, 2025 | Virginia Ruth Sanzone VP, General Counsel | FTax withholding Common Stock | -898 | $143.45 | $129k | 7,086 | Mar 17, 2025 |
| Mar 15, 2025 | Daniel Woolson VP, GM-Infusion Capital | FTax withholding Common Stock | -1,294 | $143.45 | $186k | 14,194 | Mar 17, 2025 |
| Mar 15, 2025 | Christian B. Voigtlander Chief Operating Officer | FTax withholding Common Stock | -1,792 | $143.45 | $257k | 2,389 | Mar 17, 2025 |
| Mar 15, 2025 | Ben Sousa Chief Information Officer | FTax withholding Common Stock | -716 | $143.45 | $103k | 2,479 | Mar 17, 2025 |
| Mar 15, 2025 | Brian Michael Bonnell Chief Financial Officer | MOption exercise Common Stockderivative | -3,248 | $0.00 | $0 | 3,248 | Mar 17, 2025 |
| Mar 15, 2025 | Vivek Jain Chairman and CEO | FTax withholding Common Stock | -2,688 | $143.45 | $386k | 108,220 | Mar 17, 2025 |
| Mar 15, 2025 | Virginia Ruth Sanzone VP, General Counsel | MOption exercise Common Stockderivative | -1,624 | $0.00 | $0 | 1,624 | Mar 17, 2025 |
| Mar 15, 2025 | Daniel Woolson VP, GM-Infusion Capital | MOption exercise Performance Sharesderivative | -2,923 | $0.00 | $0 | 2,924 | Mar 17, 2025 |
| Mar 15, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stockderivative | -3,248 | $0.00 | $0 | 3,248 | Mar 17, 2025 |
| Mar 15, 2025 | Ben Sousa Chief Information Officer | MOption exercise Common Stockderivative | -1,299 | $0.00 | $0 | 1,300 | Mar 17, 2025 |
| Mar 15, 2025 | Vivek Jain Chairman and CEO | MOption exercise Common Stockderivative | -4,872 | $0.00 | $0 | 4,872 | Mar 17, 2025 |
| Mar 7, 2025 | Vivek Jain Chairman and CEO | AGrant or award Common Stockderivative | +15,848 | $0.00 | $0 | 15,848 | Mar 14, 2025 |
| Mar 7, 2025 | Ben Sousa Chief Information Officer | MOption exercise Common Stock | +430 | $0.00 | $0 | 1,749 | Mar 10, 2025 |
| Mar 7, 2025 | Brian Michael Bonnell Chief Financial Officer | MOption exercise Common Stock | +2,146 | $0.00 | $0 | 27,100 | Mar 10, 2025 |
| Mar 7, 2025 | Vivek Jain Chairman and CEO | FTax withholding Common Stock | -1,775 | $0.00 | $0 | 102,818 | Mar 10, 2025 |
| Mar 7, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stock | +2,146 | $0.00 | $0 | 2,146 | Mar 10, 2025 |
| Mar 7, 2025 | Virginia Ruth Sanzone VP, General Counsel | MOption exercise Common Stock | +1,073 | $0.00 | $0 | 5,555 | Mar 10, 2025 |
| Mar 7, 2025 | Daniel Woolson VP, GM-Infusion Capital | MOption exercise Common Stock | +966 | $0.00 | $0 | 11,832 | Mar 10, 2025 |
| Mar 7, 2025 | Brian Michael Bonnell Chief Financial Officer | MOption exercise Common Stockderivative | -2,146 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 7, 2025 | Vivek Jain Chairman and CEO | MOption exercise Common Stock | +3,218 | $0.00 | $0 | 106,036 | Mar 10, 2025 |
| Mar 7, 2025 | Virginia Ruth Sanzone VP, General Counsel | FTax withholding Common Stock | -625 | $141.97 | $89k | 4,930 | Mar 10, 2025 |
| Mar 7, 2025 | Ben Sousa Chief Information Officer | FTax withholding Common Stock | -260 | $141.97 | $37k | 1,489 | Mar 10, 2025 |
| Mar 7, 2025 | Christian B. Voigtlander Chief Operating Officer | FTax withholding Common Stock | -1,213 | $141.97 | $172k | 933 | Mar 10, 2025 |
| Mar 7, 2025 | Daniel Woolson VP, GM-Infusion Capital | FTax withholding Common Stock | -467 | $141.97 | $66k | 11,365 | Mar 10, 2025 |
| Mar 8, 2025 | Virginia Ruth Sanzone VP, General Counsel | MOption exercise Common Stock | +3,189 | $0.00 | $0 | 8,119 | Mar 10, 2025 |
| Mar 8, 2025 | Daniel Woolson VP, GM-Infusion Capital | MOption exercise Common Stock | +2,153 | $0.00 | $0 | 13,518 | Mar 10, 2025 |
| Mar 8, 2025 | Ben Sousa Chief Information Officer | MOption exercise Common Stock | +957 | $0.00 | $0 | 2,446 | Mar 10, 2025 |
| Mar 7, 2025 | Brian Michael Bonnell Chief Financial Officer | AGrant or award Common Stockderivative | +10,566 | $0.00 | $0 | 10,566 | Mar 10, 2025 |
| Mar 7, 2025 | Christian B. Voigtlander Chief Operating Officer | MOption exercise Common Stockderivative | -2,146 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 8, 2025 | Virginia Ruth Sanzone VP, General Counsel | FTax withholding Common Stock | -1,759 | $141.97 | $250k | 6,360 | Mar 10, 2025 |
| Mar 8, 2025 | Daniel Woolson VP, GM-Infusion Capital | FTax withholding Common Stock | -953 | $141.97 | $135k | 12,565 | Mar 10, 2025 |
| Mar 8, 2025 | Ben Sousa Chief Information Officer | FTax withholding Common Stock | -550 | $141.97 | $78k | 1,896 | Mar 10, 2025 |
| Mar 7, 2025 | Vivek Jain Chairman and CEO | MOption exercise Common Stockderivative | -3,218 | $0.00 | $0 | 0 | Mar 10, 2025 |
| Mar 7, 2025 | Christian B. Voigtlander Chief Operating Officer | AGrant or award Common Stockderivative | +10,566 | $0.00 | $0 | 10,566 | Mar 10, 2025 |
| Mar 7, 2025 | Virginia Ruth Sanzone VP, General Counsel | MOption exercise Common Stockderivative | -1,073 | $0.00 | $0 | 0 | Mar 10, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Donald Abbeydirector
- Brian Michael BonnellChief Financial Officer
- Elisha W Finneydirector
- David C. Greenbergdirector
- Laurie Hernandezdirector
- David F Hoffmeisterdirector
- Vivek JainChairman and CEO
- Kolleen T Kennedydirector
- Virginia Ruth SanzoneVP, General Counsel
- Ben SousaChief Information Officer
- Christian B. VoigtlanderChief Operating Officer
- Daniel WoolsonVP, GM-Infusion Capital
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.